ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
35 hedge funds and large institutions have $2.74M invested in Oncternal Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
-8
Holders Change %
-18.6%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
17
Closed
12
Calls
$73K
Puts
$18K
Net Calls
+$55K
Net Calls Change
+$46K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$282K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$280K |
| 3 |
SG Americas Securities
New York
|
+$41K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.5K |
| 5 |
Two Sigma Advisers
New York
|
+$9.24K |
Top Sellers
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$381K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$207K |
| 3 |
Two Sigma Investments
New York
|
-$102K |
| 4 |
State Street
Boston,
Massachusetts
|
-$87.7K |
| 5 |
VF
Virtu Financial
New York
|
-$66K |
